For evaluation of drugs and screening of potential inhibitors to chymotrypsin proteases. Safe. Non-radioactive assay. Homogeneous and convenient. Homogenous “Mix-incubate-measure” type assay. No wash and reagent transfer steps are involved. Robust and High-throughput. Can be readily automated to assay thousands of samples per day. Robust assay with a Z’ factor of >0.8. Method: FL485/530 nm; Samples: Compounds that affect chymotrypsin protease activity. Species: All; Procedures: 45 min.